(Q64029808)
Statements
A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period (English)
0 references
February 2012
0 references
December 2013
0 references
417
0 references
18 year
0 references